u.s. bioscienc share lost near half valu monday
heavi trade follow late friday decis
food drug administr panel approv ethyol
panel said drug show much promis suffici
data gather support indic use
analyst follow biotechnolog compani expect
favor decis
west conshohockon pa. compani share trade
sever week ago high $ 44 2-for-1 split
decemb close yesterday $ 19.25 $ 1.50 new
york stock exchang composit trade
h. robert fiebach outsid attorney u.
bioscienc said review one suit far
confid case dismiss earli
process invest public knew fda
approv process risk busi
depend fda review mr. fiebach said fda approv
automat
attorney sever plaintiff could
reach comment
